Unilateral change in 2017 PMAP and how to counter it

Food and Drug Administration (FDA) logoBargaining unit employees (BUEs) in the Office of Regulatory Affairs (ORA) have noticed a change to your 2017 Performance Management Appraisal Program (PMAP) form that reads:

NOTE: This element relates to the ORA Associate Commissioner for Regulatory Affairs (ACRA) 2017 Priority Initiative for Leading Change, Program Critical Element #1, HHS SES Executive Performance Plan:

  • Support the President’s Employee Engagement initiative by participating in opportunities to provide feedback, including participating in: focus groups, town halls, work groups or project teams and special workplace initiatives (i.e. complete the annual EVS, nominate peers for an ORA Values Award, participate in your division/office EVS action planning, complete/monitor your IDP, provide regular feedback through surveys, town halls, meetings).

  • Act in accordance with the Office of Regulatory Affairs Core Values, and participate in ORA sponsored activities to learn how to continuously demonstrate behaviors in the areas of accountability, commitment to public health, communication, diversity and inclusion, integrity and respect and quality.  Participate in at least one agency (or otherwise) offered or supported training in the areas of diversity and inclusion and other ORA core values that advance and support ORA core values in the workplace.

Continue reading “Unilateral change in 2017 PMAP and how to counter it”